PRKACB anticorps (N-Term)

N° du produit ABIN928850

L’anticorps anti-PRKACB Polyclonal Lapin est utilisé pour la détection de PRKACB dans des échantillons de Humain. Il a été validé pour WB.

Aperçu rapide pour PRKACB anticorps (N-Term) (ABIN928850)

Antigène: PRKACB (Protein Kinase, CAMP Dependent, Catalytic, beta (PRKACB))

Reactivité: Humain

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp PRKACB est non-conjugé

Application: Western Blotting (WB)

Détail du produit anti-PRKACB anticorps

Épitope: N-Term

Purification: Purified

Immunogène: PRKACB antibody was raised in rabbit using the N terminal of PRKACB as the immunogen

Information d'application

Indications d'application: WB: 0.2-1 µg/mL
Optimal conditions should be determined by the investigator.

Commentaires:

PRKACB Blocking Peptide, (ABIN5615552), is also available for use as a blocking control in assays to test for specificity of this PRKACB antibody

Restrictions: For Research Use only

Stockage

Format: Lyophilized

Concentration: Lot specific

Buffer: Lyophilized powder. Add 50 µL of distilled water. Final antibody concentration is 1 mg/mL in PBS buffer.

Conseil sur la manipulation: Avoid repeated freeze/thaw cycles.

Stock: 4 °C/-20 °C

Stockage commentaire: Store at 4 °C, following reconstitution, aliquot and store at -20 °C.

Détails sur PRKACB

Antigène: PRKACB (Protein Kinase, CAMP Dependent, Catalytic, beta (PRKACB))

Autre désignation: PRKACB

Sujet: CAMP is a signaling molecule important for a variety of cellular functions. cAMP exerts its effects by activating the cAMP-dependent protein kinase, which transduces the signal through phosphorylation of different target proteins. The inactive kinase holoenzyme is a tetramer composed of two regulatory and two catalytic subunits. cAMP causes the dissociation of the inactive holoenzyme into a dimer of regulatory subunits bound to four cAMP and two free monomeric catalytic subunits. Synonyms: Polyclonal PRKACB antibody, Anti-PRKACB antibody, protein kinase, cAMP-dependent, catalytic, beta antibody, DKFZp781I2452 antibody, MGC41879 antibody, MGC9320 antibody, PKACB antibody.

Pathways: AMPK Signaling, Signalisation Hedgehog, EGFR Signaling Pathway, Neurotrophin Signaling Pathway, Thyroid Hormone Synthesis, Myometrial Relaxation and Contraction, M Phase, G-protein mediated Events, Interaction of EGFR with phospholipase C-gamma, Lipid Metabolism